High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.
Julie C NienstedtAlexander GröbeTill ClauditzRonald SimonAdrian MuenscherRainald KnechtGuido SauterChristoph MoebiusMarco BlessmannMax HeilandChristina PflugPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2017)
Despite lacking prognostic utility in HNSCC, the remarkable high prevalence of TUBB3 expression in HNSCC emphasizes its putative relevance as a target for future drugs targeting TUBB3.